Hematología. Trasplante Hematopoyético y Terapia Celular

Foto de Hematología. Trasplante Hematopoyético y Terapia Celular

Foto de Harvard Medical School

Harvard Medical School

Boston, Estados Unidos

Publicaciones en colaboración con investigadores/as de Harvard Medical School (7)

2024

Endothelial injury and dysfunction with emerging immunotherapies in multiple myeloma, the impact of COVID-19, and endothelial protection with a focus on the evolving role of defibrotide
Blood Reviews, Vol. 66

2022

Distinctive Biomarker Features in the Endotheliopathy of COVID-19 and Septic Syndromes
Shock (Augusta, Ga.), Vol. 57, Núm. 1, pp. 95-105

2021

COVID-19-induced endotheliitis: emerging evidence and possible therapeutic strategies
British Journal of Haematology
Defibrotide: potential for treating endothelial dysfunction related to viral and post-infectious syndromes
Expert Opinion on Therapeutic Targets, Vol. 25, Núm. 6, pp. 423-433
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
Autophagy, Vol. 17, Núm. 1, pp. 1-382

2016

Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356
Autophagy
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)
Autophagy, Vol. 12, Núm. 1, pp. 1-222